Volume | 138,216 |
|
|||||
News | - | ||||||
Day High | 1.3643 | Low High |
|||||
Day Low | 1.21 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Femasys Inc | FEMY | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.33 | 1.21 | 1.3643 | 1.27 | 1.325 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
455 | 138,216 | US$ 1.28 | US$ 177,292 | - | 0.2479 - 4.75 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:52:21 | 30 | US$ 1.26 | USD |
Femasys Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
27.5M | 21.65M | - | 1.07M | -14.25M | -0.66 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Femasys News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FEMY Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.30 | 1.41 | 1.21 | 1.31 | 177,874 | 0.00 | 0.00% |
1 Month | 1.54 | 1.84 | 1.21 | 1.50 | 344,610 | -0.24 | -15.58% |
3 Months | 0.80 | 2.40 | 0.75 | 1.62 | 770,541 | 0.50 | 62.50% |
6 Months | 1.18 | 2.40 | 0.734 | 1.33 | 758,215 | 0.12 | 10.17% |
1 Year | 0.832 | 4.75 | 0.2479 | 1.81 | 3,753,403 | 0.468 | 56.25% |
3 Years | 13.08 | 13.75 | 0.2479 | 1.93 | 1,401,436 | -11.78 | -90.06% |
5 Years | 13.08 | 13.75 | 0.2479 | 1.93 | 1,401,436 | -11.78 | -90.06% |
Femasys Description
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. |